Stockreport

Adaptive Phase II Study of BAN2401 in Early Alzheimer’s Disease Continues toward 18-Month Endpoint

Biogen Inc.  (BIIB) 
Last biogen inc. earnings: 4/22 07:12 am Check Earnings Report
US:NASDAQ Investor Relations: biogen.com/en_us/investors.html
PDF Criteria for Success at 12-Month Analysis of ADCOMS Not Met Study to Remain Blinded Per Protocol until Final Readout of Comprehensive 18-Month Da [Read more]